Stocktoria
Context Therapeutics Inc. CNTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-10-20
Context Therapeutics Inc. statistics & valuation
Market cap$53.3M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -52.7% | -27.2% | -149.2% | -39.1% | -20.4% |
| Return on equity | -59.7% | -28.1% | -201.9% | -42.7% | -21.7% |
| Current ratio | 8.52 | 35.62 | 3.83 | 11.80 | 16.90 |
Source: SEC EDGAR filings · CIK 0001842952 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.